Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Apyx Medical Corp (APYX)

Apyx Medical Corp (APYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 45,730
  • Shares Outstanding, K 34,644
  • Annual Sales, $ 52,350 K
  • Annual Income, $ -18,710 K
  • 60-Month Beta 1.09
  • Price/Sales 0.92
  • Price/Cash Flow N/A
  • Price/Book 1.78
Trade APYX with:

Options Overview Details

View History
  • Implied Volatility 164.69% ( +9.74%)
  • Historical Volatility 124.47%
  • IV Percentile 96%
  • IV Rank 35.63%
  • IV High 367.02% on 03/22/24
  • IV Low 52.69% on 05/01/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 12
  • Volume Avg (30-Day) 51
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 9,304
  • Open Int (30-Day) 8,943

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -80.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2100 +14.05%
on 03/22/24
1.9000 -27.37%
on 03/20/24
-0.3900 (-22.03%)
since 03/18/24
3-Month
1.2100 +14.05%
on 03/22/24
2.8000 -50.71%
on 02/06/24
-0.6100 (-30.65%)
since 01/18/24
52-Week
1.2100 +14.05%
on 03/22/24
7.9700 -82.69%
on 06/28/23
-1.6200 (-54.00%)
since 04/18/23

Most Recent Stories

More News
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Misses Revenue Estimates

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of -60% and 12.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BLFS : 15.86 (+4.76%)
APYX : 1.3800 (+4.55%)
ZimVie Inc. (ZIMV) Tops Q1 Earnings and Revenue Estimates

ZimVie Inc. (ZIMV) delivered earnings and revenue surprises of 525% and 9.16%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ZIMV : 15.68 (+2.28%)
APYX : 1.3800 (+4.55%)
RENUVION® RECEIVES FDA CLEARANCE FOR SPECIFIC USE AFTER LIPOSUCTION

/PRNewswire/ -- Apyx Medical Corporation (NASDAQ: APYX), the manufacturer of the proprietary helium plasma and radiofrequency technology marketed and sold as...

APYX : 1.3800 (+4.55%)
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced it has received...

APYX : 1.3800 (+4.55%)
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that financial...

APYX : 1.3800 (+4.55%)
Renuvion Wins ADDY® Award for #ThisIsMe Campaign

/PRNewswire/ -- Apyx Medical Corporation (NASDAQ:APYX), the manufacturer of the proprietary helium plasma and radiofrequency technology marketed and sold as...

APYX : 1.3800 (+4.55%)
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported financial results...

APYX : 1.3800 (+4.55%)
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced it has received...

APYX : 1.3800 (+4.55%)
Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap Financial

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that the Company...

APYX : 1.3800 (+4.55%)
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today announced that financial...

APYX : 1.3800 (+4.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly...

See More

Key Turning Points

3rd Resistance Point 1.5567
2nd Resistance Point 1.4733
1st Resistance Point 1.4267
Last Price 1.3800
1st Support Level 1.2967
2nd Support Level 1.2133
3rd Support Level 1.1667

See More

52-Week High 7.9700
Fibonacci 61.8% 5.3877
Fibonacci 50% 4.5900
Fibonacci 38.2% 3.7923
Last Price 1.3800
52-Week Low 1.2100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar